期刊
ONCOTARGET
卷 8, 期 42, 页码 72260-72271出版社
IMPACT JOURNALS LLC
DOI: 10.18632/oncotarget.20139
关键词
gingerol; breast cancer; cell cycle; apoptosis; animal models
资金
- Sao Paulo Research Foundation (FAPESP) [2013/00798-2, 2015/24940-8]
- National Breast Cancer Foundation [IN-16-036]
- Cancer Australia [1067045]
- CNPq
- CAPES
- FAPESP [2012/03771-5, 2012/18908-6]
- National Breast Cancer Foundation [PS-17-006] Funding Source: researchfish
There is increasing interest in the use of non-toxic natural products for the treatment of various pathologies, including cancer. In particular, biologically active constituents of the ginger oleoresin (Zingiber officinale Roscoe) have been shown to mediate anti-tumour activity and to contribute to the anti-inflammatory, antioxidant, antimicrobial, and antiemetic properties of ginger. Here we report on the inhibitory properties of [10]-gingerol against metastatic triple negative breast cancer (TNBC) in vitro and in vivo. We show that [10]-gingerol concentration-dependently induces apoptotic death in mouse and human TNBC cell lines in vitro. In addition, [10]-gingerol is well tolerated in vivo, induces a marked increase in caspase-3 activation and inhibits orthotopic tumour growth in a syngeneic mouse model of spontaneous breast cancer metastasis. Importantly, using both spontaneous and experimental metastasis assays, we show for the first time that [10]-gingerol significantly inhibits metastasis to multiple organs including lung, bone and brain. Remarkably, inhibition of brain metastasis was observed even when treatment was initiated after surgical removal of the primary tumour. Taken together, these results indicate that [10]-gingerol may be a safe and useful complementary therapy for the treatment of metastatic breast cancer and warrant further investigation of its efficacy, either alone or in combination with standard systemic therapies, in pre-clinical models of metastatic breast cancer and in patients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据